Oncogene (Oncogene)

Oncogene is a leading international journal dedicated to publishing cutting-edge research in cancer biology and molecular oncology. Established in 1987, it focuses on understanding the genetic and molecular mechanisms that drive cancer initiation, progression, and metastasis. The journal covers a broad spectrum of topics including oncogene function, tumor suppressor genes, cell cycle regulation, apoptosis, epigenetics, cancer genomics, and targeted therapies. It also emphasizes translational research that bridges laboratory discoveries with clinical applications in oncology. Oncogene publishes original research articles, reviews, and short communications that significantly contribute to the advancement of cancer science. With a weekly publication schedule, it ensures rapid dissemination of important findings to the global scientific community. The journal is part of the Nature Portfolio under Springer Nature, known for its high editorial standards and rigorous peer-review process. Oncogene plays a critical role in shaping modern cancer research by highlighting innovative studies that improve understanding of tumor biology and support the development of new therapeutic approaches. Its readership includes molecular biologists, oncologists, geneticists, and biomedical researchers worldwide.

Oncogene (Oncogene) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, Cancer Biology, Molecular Biology, Genetics, Cell Signaling and Tumor Research, The journal is widely recognized in oncology, molecular biology, biomedical research communities, It emphasizes studies on tumor biology, signaling pathways, gene regulation, cancer therapeutics , Online or Print , weekly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0950-9232, E-ISSN: 1476-5594, Established: 1987,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE